Dr. Faith Davies from the Myeloma Institute joins Patient Power to describe some common medical terms and phrases and what they mean for myeloma patients. See the video.
Gareth Morgan, M.D., Ph.D., director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy, was named an Arkansas Research Alliance (ARA) Scholar at a news conference August 27, 2014 at the State Capitol. Read more.
The Castleman Disease Collaborative Network (CDCN) – a global network of physicians, researchers, patients, and loved ones that is accelerating research and treatment for Castleman disease – has launched a new website at www.castlemannetwork.org. The CDCN is taking an innovative approach to tackling this rare and deadly hematologic inflammatory disorder that involves global collaboration, investments in high-impact research, patient engagement, and strategic partnerships. Check out their website at www.castlemannetwork.org
Please welcome internationally recognized clinician and researcher, Dr. Faith Davies, to the Myeloma Institute! Dr Davies is a professor of medicine and is the Director of the Phase I Clinical Trials Program for both the Myeloma Institute and the Winthrop P. Rockefeller Cancer Institute…Read more
Dr. Frits van Rhee has two new publications on Castleman’s Disease:
UAMS WELCOMES Dr. Gareth Morgan as the new Director of the Myeloma Institute. Dr. Morgan joins us from the Institute of Cancer Research in London. Dr. Bart Barlogie, founder of the Myeloma Institute, will continue to see patients and conduct research.
Check out the news interview at http://www.katv.com/video?clipId=10205770&autostart=true with Dr. Frits van Rhee and his work toward the FDA approval of Sylvant, the first of its kind approved for Multi-centric Castleman Disease.
Read A Story of Life, an article featured in the May edition of Arkansas Life magazine.
Read the article published in the May 11, 2014, edition of the Arkansas Democrat Gazette on Dr. Frits van Rhee and his work leading to FDA approval of Sylvant used for the treatment of Multi-centric Castleman Disease.
View the news video of the Myeloma Institute’s announcement on April 22.
World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., will assume Leadership at the (UAMS) Myeloma Institute for Research and Therapy (MIRT), effective July 1… Read More
Governor Mike Beebe proclaims the month of March as Myeloma Awareness Month!
From “In Arkansas” magazine read Notable Neighbors: Dr. Bart Barlogie of Hillcrest
Listento Dr. Frits van Rhee’s discussion of the Total Therapy program for myeloma on CurePanel